Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China SXT Pharmaceuticals (SXTC) Non-Current Assets (2018 - 2025)

Historic Non-Current Assets for China SXT Pharmaceuticals (SXTC) over the last 8 years, with Q3 2025 value amounting to $310889.0.

  • China SXT Pharmaceuticals' Non-Current Assets fell 9654.91% to $310889.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $310889.0, marking a year-over-year decrease of 9654.91%. This contributed to the annual value of $367017.0 for FY2025, which is 9587.33% down from last year.
  • China SXT Pharmaceuticals' Non-Current Assets amounted to $310889.0 in Q3 2025, which was down 9654.91% from $367017.0 recorded in Q1 2025.
  • In the past 5 years, China SXT Pharmaceuticals' Non-Current Assets ranged from a high of $11.3 million in Q1 2021 and a low of $310889.0 during Q3 2025
  • Moreover, its 5-year median value for Non-Current Assets was $9.4 million (2022), whereas its average is $7.3 million.
  • Its Non-Current Assets has fluctuated over the past 5 years, first skyrocketed by 72450.46% in 2024, then crashed by 9654.91% in 2025.
  • China SXT Pharmaceuticals' Non-Current Assets (Quarter) stood at $11.0 million in 2021, then fell by 10.79% to $9.8 million in 2022, then plummeted by 88.87% to $1.1 million in 2023, then soared by 724.5% to $9.0 million in 2024, then plummeted by 96.55% to $310889.0 in 2025.
  • Its Non-Current Assets was $310889.0 in Q3 2025, compared to $367017.0 in Q1 2025 and $9.0 million in Q3 2024.